Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer.
about
Molecular classification of gastric cancer: Towards a pathway-driven targeted therapyA rare case of poorly differentiated thyroid carcinoma probably arising from a nodular goiterPrognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review.Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.G-protein coupled receptor 34 knockdown impairs the proliferation and migration of HGC-27 gastric cancer cells in vitroMutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers.Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy.Advancing pharmacological treatment options for advanced gastric cancer.Direct targeting of HGF by miR-16 regulates proliferation and migration in gastric cancer.Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing.PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer.Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing.KRAS, KIT and TP53 mutations in mother's and daughter's gastric cardia adenocarcinomas.Genome-wide Analyses on Single Disease Samples for Potential Biomarkers and Biological Features of Molecular Subtypes: A Case Study in Gastric Cancer.Mutation Status and Immunohistochemical Correlation of , and in 260 Chinese Colorectal and Gastric Cancers
P2860
Q26798420-4AA302CD-DF45-4B05-87F2-31932691A438Q33759697-ABD611EA-49CE-4FAD-88FD-55ABFBF78D73Q36070010-508B5F42-8109-4D7D-B408-C8CAFD643377Q36547753-426E7BB6-A8FC-4E08-9C7D-2FD573B26A28Q36811701-4384DE8B-74BC-4D4A-9B50-2833F289077EQ36905878-8DDC7E52-8818-42A0-ACAD-D7B7F4D8EFD8Q38527414-E033F71C-EACB-46AA-AF1A-FA4DD8124200Q38584644-EFED1CFC-B5B0-4CBB-8FF7-8535FFE7B027Q38816624-33618872-5054-4302-9FD4-562AE34E950AQ47106128-B3A0AA98-E275-4793-A9B5-A1670622E13DQ47157362-07656F19-9B15-46AB-AC37-F19035D2DC59Q47200284-29F96D3D-D96A-478C-9CE8-A5396C98EBE1Q55253585-5F9A9674-BFA6-4A95-9E55-30172CCA78D1Q55513279-C78B9F77-203E-408A-8C71-9C1C152CC643Q58707595-B39FB56D-9025-4D7E-8C2F-BE892FF3B53D
P2860
Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinicopathological features a ...... ns in advanced gastric cancer.
@ast
Clinicopathological features a ...... ns in advanced gastric cancer.
@en
Clinicopathological features a ...... ns in advanced gastric cancer.
@nl
type
label
Clinicopathological features a ...... ns in advanced gastric cancer.
@ast
Clinicopathological features a ...... ns in advanced gastric cancer.
@en
Clinicopathological features a ...... ns in advanced gastric cancer.
@nl
prefLabel
Clinicopathological features a ...... ns in advanced gastric cancer.
@ast
Clinicopathological features a ...... ns in advanced gastric cancer.
@en
Clinicopathological features a ...... ns in advanced gastric cancer.
@nl
P2093
P2860
P356
P1433
P1476
Clinicopathological features a ...... ns in advanced gastric cancer.
@en
P2093
Atsuo Takashima
Hirokazu Shoji
Hirokazu Taniguchi
Masaru Fukahori
Naoki Takahashi
Satoru Iwasa
Tetsuya Hamaguchi
Yasuhide Yamada
Yasuhiro Shimada
P2860
P2888
P356
10.1186/1756-0500-7-271
P577
2014-04-29T00:00:00Z
P5875
P6179
1050625114